Brain tumor drug testing using 3D models in children
Part of Brain & nervous system, Cancer, Genetic & congenital clinical trials.
This study creates 3D models from brain tumor tissue of children aged 3-18 to test how different drugs might work against their specific tumor. The goal is to find more personalized treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 3 and 18 years old
- You have a suspected brain tumor and are scheduled for surgery
- You have not had a bone marrow transplant or other blood-related procedure that could affect genetic tests
- You have not received any cancer treatments (chemotherapy, radiation, or targeted therapy) before this surgery
- You or your guardian must sign a consent form agreeing to participate
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at brain tumor samples from children and young adults after surgery to learn more about the tumors and find better treatments. It may help researchers develop new therapies for these tumors.
This trial uses a small piece of your brain tumor after surgery to test which drugs might work best for you. It helps doctors find the most effective treatment for your specific tumor.
This study looks at genetic (DNA/molecular) features of malignant brain tumors in children. It may help doctors better understand tumor risk patterns and guide future treatment planning.
This study tests a new way to choose treatment for people with brain tumors that have not responded to standard therapies. Your tumor sample is analyzed in the lab to find which drugs might work best for you, and then you receive a personalized treatment plan.
This trial takes a small sample of your tumor to grow a model in the lab. This model helps doctors test which treatments might work best for you.
This trial studies how personalized (tailored) genetic testing can help guide care for children with cancer. It may help match treatment choices to each child’s genetic risk, and it includes optional return of germline (inherited) test results.
Hear when a new Genomics trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.